0000899243-21-023721.txt : 20210614
0000899243-21-023721.hdr.sgml : 20210614
20210614201146
ACCESSION NUMBER: 0000899243-21-023721
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210610
FILED AS OF DATE: 20210614
DATE AS OF CHANGE: 20210614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sulzberger Gabrielle
CENTRAL INDEX KEY: 0001262388
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39311
FILM NUMBER: 211016336
MAIL ADDRESS:
STREET 1: 450 LEXINGTON AVENUE, FLOOR 13
CITY: NEW YORK
STATE: NY
ZIP: 10017
FORMER NAME:
FORMER CONFORMED NAME: Greene-Sulzberger Gabrielle
DATE OF NAME CHANGE: 20141030
FORMER NAME:
FORMER CONFORMED NAME: GREENE GABRIELLE E
DATE OF NAME CHANGE: 20030904
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cerevel Therapeutics Holdings, Inc.
CENTRAL INDEX KEY: 0001805387
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 131 DARTMOUTH STREET
STREET 2: SUITE 502
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 844-304-2048
MAIL ADDRESS:
STREET 1: 131 DARTMOUTH STREET
STREET 2: SUITE 502
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp II
DATE OF NAME CHANGE: 20200303
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-10
0
0001805387
Cerevel Therapeutics Holdings, Inc.
CERE
0001262388
Sulzberger Gabrielle
C/O CEREVEL THERAPEUTICS HOLDINGS, INC.
222 JACOBS STREET, SUITE 200
CAMBRIDGE
MA
02141
1
0
0
0
Stock Option (Right to Buy)
13.93
2021-06-10
4
A
0
58003
0.00
A
2031-06-10
Common Stock
58003
58003
D
100% of the shares subject to this option shall vest and become exercisable on the earlier of: (i) the one year anniversary of the Grant Date, or (ii) the next annual meeting of stockholders of the Company occurring after the Grant Date.
/s/ Mark Bodenrader, as Attorney-in-Fact
2021-06-14